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ABSTRACT
O bjective : The aim of this study was to analyse 
the conditions of the penetrating keratoplasties 
(PK) performed at Haydarpaşa Numune Hospital 
over 2 years time, and to compare the outcome 
with previous studies.
Method: Forty-five eyes of 40 patients were 
investigated retrospectively. Donor corneas were 
trephined to 7.00-7.50 mm sized buttons. In 30 
eyes continuous, and in 15 eyes interrupted 
sutures were used. Eight procedures were 
combined with extracapsular cataract extraction. 
Postoperative treatment consisted of topical 
antibiotic, corticosteroid, mydriatic, and artificial 
tear drops. If required, additional treatment was 
initiated.
R e su lts : Thirty-nine procedures were primary 
PK, 6 were rekeratoplasties. The most frequent 
indication for PK was corneal leucoma. No 
serious intraoperative complication was 
observed. A clear corneal graft was obtained in 
77.8% after a follow-up of 4-31 months. Visual 
acuity increased in 35 eyes. The most frequent 
postoperative complication was glaucoma. 
Primary graft failure was observed in 2, and 
immunologic graft failure in 5 eyes. 
Rekeratoplasty was performed in 3 eyes.
C o n c lu s io n : The results of our study are 
comparable to previous studies. Even with the 
inclusion of high-risk PK, the frequency of
obtaining a clear corneal graft is high, and is 
likely to increase further with rigid eyebanking 
procedures and ABO blood group-matching.
K ey W o rd s: Penetrating keratoplasty, Graft 
rejection, Eyebanking.
INTRO DUC TION
Penetrating keratoplasty (PK) is the most 
frequently performed and the most successful 
form of tissue transplantation. Due to 
ameliorations in donor banking, microsurgical 
equipment, and rejection therapy; postoperative 
results are constantly improving (1,2). PK can be 
performed in combination with cataract 
extraction, with or without intraocular lens (IOL) 
implantation (3-6). Although preoperative risk 
factors have been established, graft rejection 
remains a serious problem (6-10).
The aim of this study was to analyse the 
preoperative conditions and the postoperative 
results of our keratoplasty cases, to compare 
possible risk factors for graft failure and 
postoperative complications, and the outcome 
with previous studies.
MATERIALS A N D  METHODS
All the cases of PK (n=45), performed at the 
Ophthalmology Clinic I of Haydarpaşa Numune 
Hospital, have been enrolled in the study.
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Preoperatively, anamnesis was obtained, and all 
patients had a full ophthalmologic examination, 
including preoperative best-corrected visual 
acuity (BCVA), biomicroscopy, and fundoscopy. 
Intraocular pressure (IOP) was measured by 
applanation tonometry if possible. In eyes with 
medium opacities, B-scan ultrasonography was 
performed.
All operations were performed by 3 surgeons 
under general or subtenon anesthesia. Donor 
corneas were harvested under sterile conditions 
within 1/2 -6  hours (mean 3.8 hours) of death. 
Mean donors age was 46.5 years (range 16-70 
years). Donor corneas with a surrounding 
scleral ring of approximately 1 mm were 
preserved in Optisol solution for a duration of 1- 
7 days at +4°C, and fashioned from the 
endothelial side with a disposable hand-hold 
vacuum punch to 7.00-7.50 mm buttons. 
Recipient beds were trephined with a 
disposable vacuum trephine. For keratoconus 
(KC), the donor button and the recipient bed 
were of the same size, whereas for the other 
cases, graft-host disparity was 0.25-0.5 mm. 
After placement of four cardinal sutures at the 
12, 3, 6, and 9 o’clock positions, the donor 
cornea was fixed on the recipient bed with a 
single continuous 10/0 monofilament nylon 
suture in 30 eyes. In 15 eyes with vascularized 
corneas, interrupted 10/0 nylon sutures were 
used. We routinely used viscoelastic material 
during fixation of the donor cornea. In 8 eyes, 
the procedure was performed in combination 
with extracapsular cataract extraction (ECCE), 
without IOL implantation (n=2), with posterior- 
chamber IOL implantation (n=5) (triple 
procedure), and with IOL repositioning (n=1). At 
the end of the procedure, a single dose of 
gentamycine and dexamethasone was injected 
subconjunctivally.
Routine postoperative therapy consisted of 
topical antibiotic, corticosteroid, mydriatic, and 
artificial tear drops. Patients were followed-up 
with the same preoperative tests daily during 
hospitalization, then routinely at 3 daily intervals 
for 15 days, weekly for the following month, 
monthly for 3 months, 3-monthly for 1 year, and 
yearly thereafter. Primary graft failure was 
defined as graft edema that did not resolve at 
any time after PK. Immunologic graft reaction 
was diagnosed by the appearance of an
endothelial and/or epithelial rejection line, 
and/or corneal edema with anterior chamber 
inflammation, that could not be attributed to any 
evident disease. Graft failure was defined as 
irreversible corneal edema with or without 
corneal vascularisation. In cases of secondary 
glaucoma (IOP exceeding 21 mmHg), 
antiglaucomatous therapy was administered. 
Some cases required systemic corticosteroid 
and cyclosporin A therapy, and systemic 
acyclovir was administered in eyes with a 
history of herpetic keratitis. Suture adjustment 
was performed in accordance to computerized 
corneal topography. Problemless sutures were 
removed after a period of 3 months-1 year.
RESULTS
Forty-five eyes of 40 subsequent PK patients 
were investigated retrospectively. Twenty 
patients were male, and 20 female. Patient age 
ranged from 5-85 years (mean 45.3 years). 
Preoperatively, trabeculectomy had been 
performed in 1 eye, cataract extraction with or 
without IOL implantation, in 7 eyes, and repair of 
corneal penetrating injury in 6 eyes. Two patients 
had been operated on both eyes. Thirty-nine 
procedures were primary keratoplasties, 6 were 
rekeratoplasties (3 rekeratoplasties had been 
performed in other centers before, and 3 
rekeratoplasties were performed for graft failure 
in this series), In 1 of these eyes transplantation 
have been performed for the 3rd time. Indications 
for operation are shown in Table I. Mean 
preoperative BCVA was 0.07 (range light 
perception (LP)-0.4) (Table II).
No serious intraoperative complication was 
observed.
Mean follow-up period was 9.8 months (range 4- 
31 months). At the end of the follow-up period, a 
clear graft was obtained in 35 eyes (77.8%). 
Mean postoperative BCVA was 0.26 (range LP-
0.8) (Table II). In 35 eyes (77.8%) BCVA 
increased, in 9 eyes (20%) it remained at the 
same level, and in 1 eye (2.2%) it decreased. 
Low BCVA despite clear cornea was observed 
in 6 eyes (13.3%). This was due to posterior 
capsule opacification (n=2), high astigmatism 
(n=1), cataract (n=1), macular edema (n=1), 
and preexisting glaucoma (n=1). Iris prolapse,
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which required additional suture placement, 
occurred in the early postoperative period in 1 
eye. In 13 eyes (28.9%) glaucoma developed 
during the postoperative period; twelve of these 
eyes responded to topical antiglaucomatous 
medication. In 1 eye IOP stabilized after 
trabeculectomy. In 6 eyes (13.3%) peripheral 
anterior synechiae (PAS) developed. In 2 eyes 
(4.4%) amnion membrane transplantation was 
successfully performed for persistent epithelial 
defects. Arcuate astigmatic keratotomy was 
performed in 1 eye. Primary graft failure (PGF) 
was observed in 2 eyes (4.4%). One of these 
eyes also had endophthalmitis. Immunologic 
graft rejection episodes responding to medical 
therapy were observed in 3 eyes (6.7%). In 
another 5 eyes (11.1%) with immunologic graft 
rejection, graft failure occurred. Three of these 
eyes received a regraft, and in 1 of the regrafts, 
immunologic graft rejection was once more 
observed. All immunologic graft failures were 
observed after single procedures, and all the 
cases were male. Indications for primary 
keratoplasty in the immunologic graft failure 
group were as follows: bullous keratopathy 
(n=2), central corneal leucoma after penetrating 
corneal injury (n=1), and acute perforation in 1 
eye (re-rejection).
T a b le  I: Indications for penetrating keratoplasty.
Indication lor penetrating keratoplasty Number of cases (%)
Corneal leucoma 20 44.5
Regraft 6 13.4
Pseudophakie bullous keratopathy 5 11.1
Keratoconus 5 11.1
Tectonic 5 11.1
Aphakic bullous keratopathy 2 4.4
Corneal dystrophy 2 4.4
Total 45 100
T a b le  II: Distribution of best-corrected visual acuity before 
and after penetrating keratoplasty.
Best-corrected visual acuity Preoperative Postoperative
Light perception 3 1
Hand motions 10 2
Counting Fingers 18 11
0.1-0.4 14 20
>0.5 0 11
Total 45 45
DISCUSSION
Our rate of 77.8% postoperative clear corneal 
graft including high risk cases, is comparable to 
previous studies’ (11,12). Whereas in PK 
performed for KC, clear graft rates range from 
90.5% to 100% (13-15), this rate is much lower if 
PK is performed for tectonic aim or as regraft
(1,7).
Our rate of immunologic graft rejection 17.8% 
including the high risk cases, was comparable to 
previous reports. It can be as low as 2.2-15% for 
KC (13,15), and has been reported as between 
16.7% and 37.1% for tectonic PK (7,8). In 
contrast to our previous report (11), where all 
immunologic graft rejections responded to 
medical therapy, we observed 5 (11.1%) graft 
failures due to immunologic graft rejection, 
despite medical therapy. Graft failure was 
defined as irreversible corneal edema. It has 
been reported as 0-8% before (1,15), and is 
more frequent with regrafts, in aphakia, with 
anterior chamber IOL, active inflammation, 
postoperative rise in IOP, and predescemetal or 
perforated ulcers (6,9,10). In our study, 4 of the 5 
immunologic graft failure cases had the above 
risk factors, and they were all males. Jonas et al. 
(9) also reported a higher frequency of graft 
failure in males, especially if the donor was 
female. Neither HLA- nor ABO blood group­
matching were performed in our study. ABO 
blood group-matching however, may reduce the 
risk of immunologic graft failure (16,17). The 
frequency of immunologic graft failure is known 
to increase with lengthening of the follow-up 
period (9). Our study included some eyes with a 
follow-up of only 4 months, and should thus be 
regarded with care.
PGF was defined as graft edema that did not 
resolve at any time after PK, and was 
infrequently observed in our study (4.4%). This is 
in accordance with the literature (13), and was 
less than our previous study’s result (11). This 
may reflect the fact that, in contrast to our 
previous study, some of the donor eyes in this 
study were provided from an eyebank. With 
meticulous investigation of the donor corneal 
endothelium, PGF is likely to decrease.
An increase in BCVA after PK was observed in 
77.8%. This is similar to our previous study (11),
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where an increase in BCVA had been observed 
in 72.2% of the eyes. Other studies report 
increase in visual acuity (VA) between 45% for 
repeated PK and 90% for primary PK (1,8). Our 
results, including primary and repeated 
procedures, thus reflect the results of previous 
studies.
In our triple procedures, a significant increase in 
BCVA was observed in 60% of the eyes 
achieved . In both eyes that had no improvement 
of BCVA despite clear corneal graft, the reason 
was posterior capsule opacification. One graft 
was not clear in the postoperative period, and 
glaucoma and pseudophakic bullous keratopathy 
developed, but the postoperative BCVA was 
superior to the preoperative BCVA. Increase in 
BCVA of 86.7% and 86.5% have been reported 
before (3,6). A clear corneal graft can be 
obtained between 72% and 83.9% in these eyes 
(4,5), with graft failure rates between 2.6% and 
18.3% (3,4). Main complication after triple 
procedure has been reported as secondary 
glaucoma (3,5). Jonas et al. (9) found no 
difference in immunologic graft reaction rate, 
whether PK was performed alone or in 
combination with lens surgery.
From our 5 eyes with tectonic PK, 2 resulted in 
graft failure. In the remaining 3 eyes BCVA 
increased. It has been reported previously that VA 
may increase in 48.7% of these eyes, and PK is 
mainly successful in keeping the tectonic aim (7).
PAS formation is the result of inflammation and 
perforation, and an important risk factor for post­
keratoplasty glaucoma (1,18). In our study we 
observed PAS in 13.3% of eyes, but only 1 of 
these eyes developed glaucoma.
The main postoperative complication in our 
study was secondary glaucoma (28.9%). 
Glaucoma rates between 3.5% and 14% have 
been reported before (1,12,13,18,19), however 
this can be as high as 36% in PK after chemical 
burns (20). In contrast to the study of Ozkurt et 
al. (12), all but 1 of our cases responded to 
medical therapy. Risk factors for post-PK 
glaucoma have been recorded as aphakia, 
rekeratoplasty, and PK combined with other 
procedures (12,18,19). In our study, only 4 eyes 
developing glaucoma had such risk factors; 
aphakia in 1, rekeratoplasty in 1, rekeratoplasty
and triple procedure in 1, and triple procedure in 
1 case. One eye had preexisting glaucoma. 
Incidence of post-PK glaucoma is variable, 
because of different patient populations, and the 
difficulty in detecting glaucoma in these 
patients. To avoid post-PK glaucoma, 
Zimmerman et al. (21) proposed increasing the 
graft size by 0.5 mm.
In our study, the main indication for PK was 
central corneal leucoma for different reasons with 
or without corneal vascularization, followed by 
regraft. Recently, PK is not anymore as 
frequently required for aphakic or pseudophakic 
bullous keratopathy, due to the ameliorations 
made in cataract surgery (1). In several studies, 
corneal opacity and regraft are the main 
indications for PK (6,12,22), and since 1992, an 
increase in PK for KC is noted (1,20,23).
The results of our study are in accordance with 
previous studies in regard to PK indication and 
outcome. Although high-risk cases were 
included, the frequency of obtaining a clear 
corneal graft postoperatively was high. If 
performed with rigid eyebanking procedures and 
ABO blood group-matching, this frequency is 
likely to increase further.
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